Reexamining the Labeling for Biotechnology in Foods: The Species Connection

Gilhooley, Margaret

Journal: Nebraska Law Review

Volume: 82

Year: 2004

Bluebook Citation: 82 NEB. L. REV. (2004)

Author: Margaret Gilhooley: all 14 publications


Abstract

I. Introduction . . . . . 1089 II. Regulatory Framework for Biotechnology in Foods . . . . . 1096 A. FDA Safety Authority with Respect to New Plant Varieties . . . . . 1096 1. FDA Basis for Safety Regulation: The 1992 Policy Statement . . . . . 1096 2. Emergent Uses and FDA’s 2001 Proposal for Pre-Market Notice . . . . . 1097 B. FDA Safety Regulation for Animal Biotechnology: Growth and Yield Promotion . . . . . 1098 C. Pest and Crop Protection Uses of Biotechnology . . . . . 1098 D. FDA’s Policy Statement on Labeling of Biotechnology in Foods . . . . . 1100 1. Material Omissions and Process . . . . . 1100 2. Food Names and Ingredient Labeling . . . . . 1101 III. Statutory and Constitutional Limits on Biotechnology Labeling: Litigation and the Deception Rationale . . . . . 1101 A. Litigation on FDA’s Statutory Authority and Policy . . . . . 1102 1. Litigation on Recombinant BST in Milk . . . . . 1102 2. Litigation on General FDA Policy Statement on Labeling . . . . . 1102 B. Constitutional Challenge to State-Mandated Labeling for rBST in Milk . . . . . 1103 C. Deception Theory for Labeling . . . . . 1103 1. Deception and Food Constituents Changed by the Process . . . . . 1103 IV. Framework and Rationale for Additional Labeling . . . . . 1105 A. Labeling for Gene Transfers from Different Species in New Plant Varieties . . . . . 1105 1. Need and Labeling Format . . . . . 1105 2. Wide Crosses: Wide Crosses as Different . . . . . 1108 a. Existing Wide Crosses . . . . . 1109 3. Varieties for Which Labeling Distinction Not Needed . . . . . 1110 4. Transfers from Animal Species: The Need for Labeling . . . . . 1111 B. Plant Biotechnology for Pesticide Use and Labeling . . . . . 1112 1. Impact of Biotechnology on Need for Labeling . . . . . 1112 2. Form for General Labeling . . . . . 1113 C. Objections to Labeling and Assessment . . . . . 1114 1. Absence of Deception . . . . . 1114 2. Insufficiency of General Labeling . . . . . 1114 3. Limits on FDA’s Authority, and Labeling Exemption for Pesticide Chemicals . . . . . 1114 a. History . . . . . 1114 b. Wider Applicability of Policy? . . . . . 1115 4. Assessment of General Labeling Approach . . . . . 1116 D. Animal Biotechnology and Labeling . . . . . 1118 1. Growth Promotion and Emerging Uses . . . . . 1118 2. Species Impact and Salmon . . . . . 1119 a. Scientific Issues . . . . . 1119 b. FDA’s Statutory Authority with Respect to Environmental Impacts . . . . . 1120 c. Role for Consumer Labeling . . . . . 1121 3. Environmental Risks from Bt Pesticides in Crops . . . . . 1122 V . Conclusion . . . . . 1123

Chat with this journal article using AI

Ask CiteLaw's AI Navigator anything about this journal article, verify citations, and research related authorities. Sign up for CiteLaw free today to get started.